A third option is suppression: the United States would forgo development of ASI and stop anyone else from building it on the basis that superintelligence is just too dangerous to be unleashed on the ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Jack Clark, Anthropic’s co-founder, left on paternity leave last November. When he returned in February, he was surprised to ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

A solution to part of the Cohen-Lenstra conjecture helps resolve a long-standing mystery about quadratic forms ...

Earnings call Tesla's Q1 2026 saw a resurgence in vehicle demand across key regions, record order backlogs, and sequential margin improvement in autos. Management guided for over $25 billion in 2026 ...